Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04060680 · ClinicalTrials.gov registry record · NA
Extravascular ICD Pivotal Study
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 393
- Enrollment target
NCT04060680 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 393 participants.
The verdict
NCT04060680, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 393 participants
- Enrollment target
Study Summary
Pivotal Summary: The study is designed to demonstrate safety and efficacy of the Extravascular Implantable Cardioverter Defibrillator (EV ICD) System. Continued Access Summary: This study is designed to provide continued access to the Extravascular Implantable Cardioverter Defibrillator (EV ICD) System.
Interventions
- DEVICE Defibrillation using the Extravascular ICD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 393 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2024-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04060680
The ClinicalTrials.gov registry entry for NCT04060680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 393 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Defibrillation using the Extravascular ICD is the first listed.
NCT04060680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04060680 about?
NCT04060680 is a clinical study titled "Extravascular ICD Pivotal Study". Pivotal Summary: The study is designed to demonstrate safety and efficacy of the Extravascular Implantable Cardioverter Defibrillator (EV ICD) System. Continued Access Summary: This study is designed to provide continued access to the Extravascular Implantable Cardioverter Defibrillator (EV ICD) ...
What is the current status of trial NCT04060680?
This trial is currently completed. It is a NA study. The enrollment target is 393 participants. The study started on 2019-09-16. Estimated completion is 2024-01-04.
What interventions are being tested in trial NCT04060680?
The interventions under investigation include: Defibrillation using the Extravascular ICD (DEVICE).
Who is sponsoring clinical trial NCT04060680?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.